We serve Chemical Name:Ethyl 3,3-dimethoxypropanoate CAS:262293-82-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Ethyl 3,3-dimethoxypropanoate
CAS.NO:262293-82-3
Synonyms:S14-2060;Ethyl 3,3-dimethoxypropionate
Molecular Formula:C7H14O4
Molecular Weight:162.18400
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:199.2ºC at 760 mmHg
Density:N/A
Index of Refraction:1.408
PSA:44.76000
Exact Mass:162.08900
LogP:0.55850
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like S14-2060 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ethyl 3,3-dimethoxypropionate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,S14-2060 Use and application,Ethyl 3,3-dimethoxypropionate technical grade,usp/ep/jp grade.
Related News: Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said. Ethyl 3,3-dimethoxypropanoate manufacturer The U.K. government previously purchased more than 380 million rapid tests from Innova, to help set up programs capable of screening millions of people per day—in the run-up to offering free COVID-19 testing nationwide at least twice per week. Ethyl 3,3-dimethoxypropanoate supplier Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said. Ethyl 3,3-dimethoxypropanoate vendor In approving the first new Alzheimer’s drug in nearly 20 years, the U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows new therapies onto the market without strong evidence that they work, regulatory and scientific experts say. Ethyl 3,3-dimethoxypropanoate factory The U.K. government previously purchased more than 380 million rapid tests from Innova, to help set up programs capable of screening millions of people per day—in the run-up to offering free COVID-19 testing nationwide at least twice per week.
